Search Results

1 - 10 of 43 items :

  • Biomedical Engineering x
Clear All
Electrochemical impedimetric detection of stroke biomarker NT-proBNP using disposable screen-printed gold electrodes

of Neurological Disorders and Stroke rt-PA Stroke Study Group. The New England journal of medicine. 1995 Dec 14;333(24):1581-7. PubMed PMID: 7477192. Epub 1995/12/14.eng. 6. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. The New England journal of medicine. 2008 Sep 25;359(13):1317-29. PubMed PMID: 18815396. Epub 2008/09/26.eng. 7. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of

Open access
Influence of OASL gene polymorphisms on host response to interferon therapy in chronic hepatitis C virus patients

, Antonelli G, Antonaci S. MxA and PKR expression in chronic hepatitis C. J Interferon Cytokine Res. 2004 Nov;24(11):659-63. PubMed PMID: 15684819. Epub2005/02/03. eng. 24. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology. 2005 May;128(5):1437-44. PubMed PMID: 15887125. Epub 2005/05/12. eng. 25. Marie I, Rebouillat D, Hovanessian AG. The expression of both domains of the 69/71 kDa 2’,5

Open access
Compared salt tolerance of five local wheat (Triticum aestivum L.) cultivars of Albania based on morphology, pigment synthesis and glutathione content

+ xanthophylls in mg/g fresh weight chla in mg/g fresh weight chlb in mg/g fresh weight tot chl carotenoids + xanthophylls in mg/g fresh weight Suba 0 mM 0.60±0.25 a 0.147±0.5 a 0.75±0.29 a 42.8±15.8 a 0.59±0.01 a 0.12±0.01 a 1.18±0.05 a 46.9±0.1 a 50 mM 0.78±0.27 a 0.21±0.08 a 0.98±0.35 a 55.4±15.9 a 1.097±0.15 b 0.17±0.05 b 0.74±0.03 b 58.22±0.56 b 100 mM 1.01±0.07 a 0.255±0.02 a 1.26±0.09 a 65.2±10.4 a 1.06±0.01 c 0.24±0.14 c 1.34±0.013 b 68.5±0.55 c 200 mM 0.77±0.26 a 0.21±0.07 a 0

Open access
Evolution of phytochemical and antioxidant activity of Tunisian carob (Ceratonia siliqua L.) pods during maturation

SK KE MN TN ZG GB Fe (μ mol/g DW) Unripe 0,40±0,00 Cc 0,21±0,00 Bb 0,37±0,00 Cc 0,25±0,00 Bb 0,17±0,00 Ca 0,91±0,00 Cd Mid-ripe 0,15±0,00 Bb 0,14±0,00 Ab 0,21±0,00 Bc 0,15±0,00 Ab 0,09±0,00 Ba 0,18±0,00 Bc Ripe 0,14±0,00 Ac 0,14±0,00 Ac 0,18±0,00 Ad 0,15±0,00 Ac 0,06±0,00 Aa 0,095±0,00 Ab Na (μ mol/g DW) Unripe 4,56±0,05 Ca 7,27±0,02 Cd 5,44±0,00 Cb 4,55±0,03 Ca 6,24±0,03 Cc 7,18±0,03 Bd Mid-ripe 4,01±0,04 Bb 6,67±0,03 Bd 5,00±0,87 Bc 3,56±0,04 Ba 5,29±0,08 Bc 7

Open access
Gastroprotective effects of methanol extract of Eremomastax speciosa leaf harvested in Southern part of Nigeria in rat

GC-MS analysis of ESE. The GC-MS chromatogram shown 6 peaks ( Fig. 1 ). The identified compounds are benzenesulfonyl chloride (40.63%), benzopyran-4-one, 5,7-dihydroxy-2-phenyl- (21.25%), benzenesulfonic acid, methyl ester (15.63%), 2(5H)-furanone, 4-methoxy-5-phenyl- (12.50%), 4,5-dimethylthiazole (4.38%) and p-chlorobenzenesulfonyl chloride (5.63%) ( Table 1 ). Table 1 Chemical composition of ESE as identified by the GC-MS S/N RT (min) % MW (g) MF Chemical name 1 30.60 40.63 176 C 6 H 5 ClO 2 S Benzenesulfonyl chloride 2

Open access
Application of whey retentate as complex nitrogen source for growth of the polyhydroxyalkanoate producer Hydrogenophaga pseudoflava strain DSM1023

provided by the Italian dairy company Latterie Vincentine S.c.a., Italy (LAVI). Separation of whey into whey permeate and whey retentate was accomplished directly at LAVI via ultrafiltration. Lactose in whey permeate was hydrolyzed enzymatically by adding the enzyme formulation Maxilact LG 2000 TM (DSM Food Specialities, UK; 2.5 mL per L whey permeate) at a pH of 6.5-7 and a temperature of 37ºC and stirring for 24 hours according to a previously published protocol ( 35 ). The whey retentate fraction was subjected towards acidic hydrolysis by adding 6 M HCl (1 mL per g

Open access
Anti-inflammatory and analgesic activities of methanol extract of Helianthus annuus Linn. (Asteraceae) leaf

.02*(52.27) 0.21 ± 0.01*(36.36) HAE 150 mg/kg 0.36 ± 0.03 (7.69) 0.29 ± 0.04*(34.09) 0.25 ± 0.03*(24.24) HAE 300 mg/kg 0.28 ± 0.03*(28.21) 0.24 ± 0.05*(45.45) 0.22 ± 0.05*(33.33) HAE 600 mg/kg 0.31 ± 0.02*(20.51) 0.24 ± 0.03*(45.45) 0.22 ± 0.03*(33.33) *p < 0.05 compared with 5% Tween-20 treated group; HAE: Helianthus annuus extract, ASA: acetylsalicylic acid Egg albumin-induced paw edema At 3 h post treatment the ASA, HAE 150, 300 and 600 mg/kg caused 35.29%, 29.41%, 32.94% and 31.76% reduction in paw volume in treated

Open access
Fluorescence lifetime imaging of red yeast Cystofilobasidium capitatum during growth

capitatum (CCY-10-1-2) was cultivated in 2l bioreactor Biostat® B plus (Sartorius) on glucose medium (60 g/l). Two-step inoculation was performed in Erlenmeyer flasks in the optimal inoculation medium (in g/l: glucose 40.0, (NH 4 )- 2 SO 4 ) 5.0, KH 2 PO 4 5, MgSO 4 ·7H 2 O 0.696, yeast extract 7.0). The first inoculum (50 ml) was cultivated for 24 h at 28 °C under continuous lighting and shaking. Inoculum I was then transferred into 0.25 l of fresh inoculum II, which was grown under the same conditions as inoculum I. After 24 h, inoculum II was transferred into a

Open access
Total nitrogen, water-soluble nitrogen and free amino acids profile during ripening of soft cheese enriched with Nigella sativa seed oil

using raw, un-pasteurized milk, with natural lactic acid bacteria. The experiment included three batches of cheese: control cheese without NSSO, 0.2% w/w NSSO enriched cheeses and 1% w/w NSSO enriched cheeses. The NSSO was added to the mildly heated milk in the respective concentrations, before renneting. The content of the Ideal ® rennet dose (8g) was diluted in 250 ml warm distilled water and 25 ml solution were added to 10 l warm milk (30-35°C), under continuous manual mixing for 10 minutes. Coagulation time was 30-45 minutes. The soft curd was left for further

Open access
Advanced approaches to produce polyhydroxyalkanoate (PHA) biopolyesters in a sustainable and economic fashion

Pseudomonas putida CA-3 for growth and PHA accumulation on pyrolyzed poly(styrene) (PS) as carbon source. Hence, the value-added conversion of a spent petrochemical plastic was combined with biosynthesis of a “bioplastic”. PS pyrolysis generates a gaseous mixture of styrene and other aromatic compounds. The gaseous substrate feed was added into the bioreactor together with the aeration stream. Rather modest volumetric PHA productivity of 0.03 g/(L·h), but high intracellular fraction in biomass of about 0.57 g/g were reported ( 57 ). A more recent report for using follow

Open access